Susceptibility to aplastic anemia is associated with HLA-DRB1*1501 in an aboriginal population in Sabah, Malaysia

Human Immunology

Volumn 72, Issue 10, 2011, Pages 889-892

  Dhaliwal, J S ^a   Wong, Lily ^b   Kamaluddin, Muhammad Amir ^a   Yin, Lee Yin ^a   Murad, Shahnaz ^a  

^a INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^b Queen Elizabeth Hospital   (Malaysia)

Author keywords

Aboriginal; Anemia; Aplastic; HLA; Susceptibility

Indexed keywords

HLA DR ANTIGEN;

ABORIGINE; ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; JAPANESE; MALAYSIA; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; ALLELES; ANEMIA, APLASTIC; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY TESTING; HLA-DRB1 CHAINS; HUMANS; INCIDENCE; LEUKOCYTES; MALAYSIA; MALE; MIDDLE AGED; PHENOTYPE;

EID: 80052963905     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.06.013     Document Type: Article

References (25)

1. Ehrlich P. Ueber einem Fall von Anamie mit Bemerkungen über regenerative Veranderungen des Knochenmarks. Charite-Analen 1888, 13:300-309. [From AA 2002.
2. Brodsky R.A., Jones R.J. Aplastic anaemia. Lancet 2005, 365:1647-1656.
3. Young N.S., Kaufman D.W. The epidemiology of acquired aplastic anemia. Haematologica 2008, 93:489-492.
4. Young N.S., Issaragrasil S., Chieh C.W., Takaku F. Aplastic anaemia in the Orient. Br J Hæmatol 1986, 62:1-6.
5. Maluf E., Hamerschlak N., Cavalcanti A.B., Júnior A.A., Eluf-Neto J., Falcão R.P., et al. Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study. Haematologica 2009, 94:1220-1226.
6. Mary J.Y., Baumelou E., Guiguet M. Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological study of aplastic anemia. Blood 1990, 75:1646-1653.
7. Başlar Z., Aktuglu G., Bolaman Z., Büyükkeçeci F., Gezer S., Kansu E., et al. Incidence of aplastic anemia in Turkey: a hospital based prospective multicentre study. Leuk Res 1997, 21:1135-1139.
8. Maluf E.M.C.P., Pasquini R., Eluf J.N., Kelly J., Kaufman D.W. Aplastic anemia in Brazil: incidence and risk factors. Am J Hematol 2002, 71:268-274.
9. Montane E., Ibanez L., Vidal X., Ballarin E., Puig R., Garica N., et al. Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica 2008, 93:518-523. Catalan Group for the Study of Agranulocytosis Aplastic Anemia.
10. Issaragrisil S., Kaufman D.W., Anderson T., Chansung K., Thamprasit T., Sirijirachai J., et al. Low drug attributability of aplastic anemia in Thailand. Blood 1997, 89:4034-4039. The Aplastic Anemia Study Group.
11. Yong A.S., Goh M., Rahman J., Menon V., Purushothaman V. Epidemiology of aplastic anemia in the state of Sabah, Malaysia. Cell Immunol 1996, 1284:S75.
12. Young N.S. Acquired aplastic anemia. Ann Intern Med 2002, 136:534-546.
13. McCahon E., Tang K., Rogers P.C.J., McBride M.L., Schultz K.R. The impact of Asian descent on the incidence of acquired severe aplastic anaemia in children. Br J Hæmatol 2003, 121:170-172.
14. Chapuis B., Von Fliedner V.E., Jeannet M., Merica H., Vuagnat P., Gratwohl A., et al. Increased frequency of DR2 in patients with aplastic anaemia and increased DR sharing in their parents. Br J Haematol 1986, 63:51-57.
15. Nimer S.D., Ireland P., Meshkinpour A., Frane M. An increased HLA DR2 frequency is seen in aplastic anemia patients. Blood 1994, 84:923-927.
16. Kapustin S.I., Popova T.I., Lyschov A.A., Togo A.V., Abdulkadyrov K.M., Blinov M.N. HLA-DR2 frequency increase in severe aplastic anemia patients is mainly attributed to the prevalence of DR15 subtype. Pathol Oncol Res 1992, 3:106-108.
17. Oguz F.A., Yalman N., Diler A.S., Oguz R., Anak S., Dorak M.T. HLA-DRB1*15 and pediatric aplastic anemia. Haematologica 2002, 87:772-774.
18. Saunthararajah Y., Nakamura R., Nam J.M., Robyn J., Loberiza F., Maciejewski J.P., et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 2002, 100:1570-1574.
19. Shao W., Tian D., Liu C., Sun X., Zhang X. Aplastic anemia is associated with HLA-DRB1*1501 in northern Han Chinese. Int J Hematol 2002, 71:350-352.
20. Incidence of aplastic anemia: the relevance of diagnostic criteria. Blood 1987, 70:1718. International Agranulocytosis and Aplastic Anemia Study.
21. Sugimori C., Yamazaki H., Feng X., Mochizuki K., Kondo Y., Takami A., et al. Roles of DRB1*1501 and DRB1*1502 in the pathogenesis of aplastic anemia. Experiment Hematol 2007, 35:13-20.
22. Führer M., Durner J., Brünnler G., Götte H., Deppner C., Bender-Götze C., et al. HLA association is different in children and adults with severe acquired aplastic anemia. Pediatr Blood Cancer 2007, 48:186-191.
23. Song E.Y., Park S., Lee D.S., Cho H.I., Park M.H. Association of human leukocyte antigen-DRB1 alleles with disease susceptibility and severity of aplastic anemia in Korean patients. Hum Immunol 2008, 69:354-359.
24. Szklo M., Sensenbrenner L., Markowitz J., Weida S., Warm S., Linet M. Incidence of aplastic anemia in Metropolitan Baltimore: a population-based study. Blood 1985, 66. 11511.
25. Dhaliwal J.S., Shahnaz M., Azrena A., Irda Y.A., Salawati M., Too C.L., et al. HLA polymorphism in three indigenous populations of Sabah and Sarawak. Tissue Antigens 2010, 75:166-169.